To investigate the difference of ERCC1 protein function in EGFR wild‐type and exon 19 deletion NSCLC cells, we detected the formation of nuclear ERCC1 foci in response to DNA cross‐linking drug cisplatin by immunofluorescence. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.